GleamWall
中文EN

WRBY Warby Parker Inc.

Ophthalmic Goods · NYSE · SEC CIK 1504776 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY9.9%
TTM net income YoY942.0%
TTM EPS YoY216,172,782,113,783,936.0%
Revenue 3-yr CAGR12.6%
Net income 3-yr CAGR—

Margins

Gross margin54.7%
Operating margin0.2%
Net margin0.8%
FCF margin2.3%
EBITDA margin6.1%

Returns

ROE1.9%
ROA1.0%
ROIC (approx.)1.1%
Asset turnover1.25x

Leverage & solvency

Liabilities / assets49.1%
Debt / equity0.00x
Current ratio2.26x
Interest coverage—

Cash quality & payout

Operating cash flow / net income13.67x
Accruals ratio-12.6%
Payout ratio—
Capex / revenue8.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$871.90M$771.32M
Cost of revenue$401.33M$344.48M
Gross profit$470.58M$426.83M
SG&A expense$475.92M$456.95M
Operating income-$5.34M-$30.11M
Pretax income$3.04M-$19.52M
Income tax$1.40M$875,000
Net income$1.64M-$20.39M
EBITDA$44.94M$15.75M
EPS (basic)0.01-0.17
EPS (diluted)0.01-0.17
Weighted avg. shares (diluted)125.10M120.39M
Balance sheet
Cash & equivalents$286.36M$254.16M
Receivables$3.29M$1.95M
Inventory$44.51M$52.34M
Current assets$352.44M$326.05M
PP&E, net$187.45M$170.46M
Total assets$720.92M$676.49M
Current liabilities$150.13M$130.35M
Total liabilities$353.19M$336.42M
Shareholders' equity$367.73M$340.07M
Cash flow statement
Operating cash flow$110.78M$98.74M
Capital expenditure$67.05M$64.03M
Free cash flow$43.74M$34.71M
Investing cash flow-$67.05M-$66.03M
Financing cash flow-$12.00M$4.96M
Depreciation & amortization$50.28M$45.87M
Stock-based compensation$34.54M$47.29M

Free plan shows the latest 2 periods; Pro shows all 7 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.